Document is current
Any future updates will be listed below
-
Authors
Cronjé, Héléne T.
Hu, Sile
Gurrell, Rachel
Vujkovic, Marijana
Larsson, Susanna C.
Mason, Richard
Butt, Richard
Gill, Dipender
-
Funding
Funding for this research was provided by:
Apollo Therapeutics Limited
- License Information
-
More Information
Article History
Received: 18 November 2025
Accepted: 16 March 2026
First Online: 23 March 2026
Declarations
:
: This study used summary data, for which ethical approval was obtained in the cited original studies.This study used summary data, and participant consent to participate was obtained in the cited original studies.
: The study only used summary data and consent for publication is therefore not required.
: D.G. is an Editorial Advisor at BMC Medicine. H.T.C., S.H. and D.G. are employees of Sequoia Genetics, a private research and development consultancy that works with investors, pharma and biotech in leveraging human genetic data to inform drug discovery and development. Sequoia Genetics received funding from Apollo Therapeutics to undertake this work. R.B., R.G. and R.M. are employees and shareholders of Apollo Therapeutics. D.G. is a Special Advisor to Apollo Therapeutics and has financial interests in several private biotechnology companies. M.V. and S.C.L. have no relevant disclosures.
